Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-21

Clinical Trial Update: Clinical Efficacy of Mouthrinses Based on Chlorhexidine 0.12% and CITROX® [NA]

View source ↗

Summary

A completed clinical trial evaluated the efficacy of chlorhexidine 0.12% mouthwash and CITROX mouthwash for periodontitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CITROX® mouthwash
  • Chlorhexidine 0.12% mouthwash (Chlorhexidine digluconate)

Snippet

Sponsor: University of L'Aquila | Conditions: Periodontitis | NA | Status: COMPLETED